Status:
COMPLETED
Comparison of Atrophogenic Effect of Hydrocortison 1% Cream and Pimecrolimus 1% Cream Assessed by Optical Coherence Tomography (OCT) and 20-MHz Ultrasound of Uninvolved Skin in Patients With Atopic Dermatitis
Lead Sponsor:
Technische Universität Dresden
Conditions:
Atopic Dermatitis
Eligibility:
All Genders
18-60 years
Phase:
PHASE2
Brief Summary
to explore the atrophogenic potentials of hydrocortison 1% cream and pimecrolimus 1% cream on unaffected forehead skin
Eligibility Criteria
Inclusion
- age 18-60 years
- diagnosis of atopic dermatitis (Hanifin \& Rajka Criteria)
- patients with atopic dermatitis not affecting the forehead
Exclusion
- pregnancy / nursing mothers
- women in reproductive age without adequate contraception
- severe atopic dermatitis (IGA \>= 4)
- UV-Therapy in past 4 weeks
- patients receiving any topical treatment on the face in past 6 month
Key Trial Info
Start Date :
December 1 2007
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 1 2009
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT00610142
Start Date
December 1 2007
End Date
January 1 2009
Last Update
June 11 2014
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Dermatology, Medical Faculty, TU Dresden
Dresden, Germany